Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial

Bibliographic Details
Main Authors: B. Marco, A. Martini, J. Pfail, G. Gandaglia, N. Fossati, S. Scuderi, G. Fallara, F. Barletta, D. Robesti, A. Rizzo, G. Basile, C.A. Bravi, G. Rosiello, L. Nocera, A. Stabile, A. Gallina, A. Salonia, F. Montorsi, A. Briganti, M.D. Galsky, W.K. Oh
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320355646
id doaj-f89ff77d2a6e40e69e5f3f15fbb03ed8
record_format Article
spelling doaj-f89ff77d2a6e40e69e5f3f15fbb03ed82020-12-30T04:22:29ZengElsevierEuropean Urology Open Science2666-16832020-10-0120S142Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trialB. MarcoA. MartiniJ. PfailG. GandagliaN. FossatiS. ScuderiG. FallaraF. BarlettaD. RobestiA. RizzoG. BasileC.A. BraviG. RosielloL. NoceraA. StabileA. GallinaA. SaloniaF. MontorsiA. BrigantiM.D. GalskyW.K. Ohhttp://www.sciencedirect.com/science/article/pii/S2666168320355646
collection DOAJ
language English
format Article
sources DOAJ
author B. Marco
A. Martini
J. Pfail
G. Gandaglia
N. Fossati
S. Scuderi
G. Fallara
F. Barletta
D. Robesti
A. Rizzo
G. Basile
C.A. Bravi
G. Rosiello
L. Nocera
A. Stabile
A. Gallina
A. Salonia
F. Montorsi
A. Briganti
M.D. Galsky
W.K. Oh
spellingShingle B. Marco
A. Martini
J. Pfail
G. Gandaglia
N. Fossati
S. Scuderi
G. Fallara
F. Barletta
D. Robesti
A. Rizzo
G. Basile
C.A. Bravi
G. Rosiello
L. Nocera
A. Stabile
A. Gallina
A. Salonia
F. Montorsi
A. Briganti
M.D. Galsky
W.K. Oh
Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial
European Urology Open Science
author_facet B. Marco
A. Martini
J. Pfail
G. Gandaglia
N. Fossati
S. Scuderi
G. Fallara
F. Barletta
D. Robesti
A. Rizzo
G. Basile
C.A. Bravi
G. Rosiello
L. Nocera
A. Stabile
A. Gallina
A. Salonia
F. Montorsi
A. Briganti
M.D. Galsky
W.K. Oh
author_sort B. Marco
title Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial
title_short Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial
title_full Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial
title_fullStr Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial
title_full_unstemmed Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial
title_sort surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the chaarted trial
publisher Elsevier
series European Urology Open Science
issn 2666-1683
publishDate 2020-10-01
url http://www.sciencedirect.com/science/article/pii/S2666168320355646
work_keys_str_mv AT bmarco surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT amartini surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT jpfail surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT ggandaglia surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT nfossati surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT sscuderi surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT gfallara surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT fbarletta surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT drobesti surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT arizzo surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT gbasile surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT cabravi surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT grosiello surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT lnocera surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT astabile surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT agallina surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT asalonia surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT fmontorsi surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT abriganti surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT mdgalsky surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
AT wkoh surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial
_version_ 1724366327309664256